Raymond James Financial Services Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$490K Sell
1,468
-1,515
-51% -$576K ﹤0.01% 2635
2024
Q2
$1.23M Buy
2,983
+672
+29% +$266K ﹤0.01% 1958
2024
Q1
$934K Buy
2,311
+1,260
+120% +$443K ﹤0.01% 2112
2023
Q4
$322K Buy
+1,051
New +$284K ﹤0.01% 2686
2017
Q1
Sell
-7,400
Closed -$267K 2472
2016
Q4
$267K Buy
+7,400
New +$246K ﹤0.01% 1866

Other funds holding MEDP

Raymond James Financial Services Advisors's MEDP Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Medpace (MEDP) stake by 51% in Q3 2024, selling an estimated $576K and leaving 1,468 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Raymond James Financial Services Advisors first reported a position in MEDP in Q4 2016 and has held it in 5 quarters since. The position peaked at $1.23M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Raymond James Financial Services Advisors held 1,468 shares of Medpace worth $490K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 1,515 Medpace shares in Q3 2024, an estimated $576K.
  • Medpace made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2635 holding.
  • Raymond James Financial Services Advisors first reported a position in Medpace in Q4 2016 and has held it in 5 quarters since.
  • Raymond James Financial Services Advisors's Medpace position peaked at $1.23M in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.